nach oben

Neuropsychology Review

Erschienen in:

01.06.2007 | Original Paper

Use of Functional Magnetic Resonance Imaging in the Early Identification of Alzheimer's Disease

verfasst von: Christina E. Wierenga, Mark W. Bondi

Erschienen in: Neuropsychology Review | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

A growing body of evidence suggests that a preclinical phase of Alzheimer's disease (AD) exists several years or more prior to the overt manifestation of clinical symptoms and is characterized by subtle neuropsychological and brain changes. Identification of individuals prior to the development of significant clinical symptoms is imperative in order to have the greatest treatment impact by maintaining cognitive abilities and preserving quality of life. Functional magnetic resonance imaging (fMRI) offers considerable promise as a non-invasive tool for detecting early functional brain changes in asymptomatic adults. In fact, evidence to date indicates that functional brain decline precedes structural decline in preclinical samples. Therefore, fMRI may offer the unique ability to capture the dynamic state of change in the degenerating brain. This review examines the clinical utility of blood oxygen level dependent (BOLD) fMRI in those at risk for AD as well as in early AD. We provide an overview of fMRI findings in at-risk groups by virtue of genetic susceptibility or mild cognitive decline followed by an appraisal of the methodological issues concerning the diagnostic usefulness of fMRI in early AD. We conclude with a discussion of future directions and propose that BOLD-fMRI in combination with cerebral blood flow or diffusion techniques will provide a more complete accounting of the neurovascular changes that occur in preclinical AD and thus improve our ability to reliably detect early brain changes prior to disease onset.

Albert, M. S., Moss, M. B., Tanzi, R., & Jones, K. (2001). Preclinical prediction of AD using neuropsychological tests. Journal of the International Neuropsychological Society, 7, 631–639.PubMedCrossRef

Backman, L., Andersson, J. L., Nyberg, L., Winblad, B., Nordberg, A., & Almkvist, O. (1999). Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology, 52, 1861–1870.PubMed

Bangen, K. J., Restom, K., Liu, T. T., Jak, A. J., Han, S. D., Fleisher, A. S., Salmon, D. P., Thal, L. J., & Bondi, M. W. (2006). Hippocampal perfusion during picture encoding: A comparison between younger and older adults. Human Brain Mapping (abstract).

Bassett, S. S., Yousem, D. M., Cristinziio, C., Kusevic, I., Yassa, M. A., Caffo, B. S., & Zeger, S. L. (2006). Familial risk for Alzheimer's disease alters fMRI activation patterns. Brain, 129, 1229–1239.PubMedCrossRef

Baxter L. C., Sparks D. L., Johnson S. C., Lenoski B., Lopez J. E., Connor D. J., & Sabbagh M. N. (2006). Relationship of cognitive measures and gray and white matter in Alzheimer's disease. Journal of Alzheimers Disorder, 9, 253–260.

Becker, J. T., Mintun, M. A., Aleva, K., Wiseman, M. B., Nichols, T., & DeKosky, S. T. (1996). Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease. Neurology, 46, 692–700.PubMed

Bentourkia, M., Bol, A., Ivanoiu, A., Labar, D., Sibomana, M., Coppens, A., Michel, C., Cosnard, G., & De Volder, A. G. (2000). Comparison of regional cerebral blood flow and glucose metabolism in the normal brain: Effect of aging. Journal of Neurological Sciences, 181, 19–28.CrossRef

Blackwell, A. D., Sahakian, B. J., Vessey, R., Semple, J. M., Robbins, T. W., & Hodges, J. R. (2004). Detecting dementia: Novel neuropsychological markers of preclinical Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 17, 42–48.PubMedCrossRef

Bondi, M. W., Houston, W. W., Eyler, L. T., & Brown, G. G. (2005). fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer's disease. Neurology, 64, 501–508.PubMed

Bondi, M. W., Monsch, A. U., Galasko, D., Butters, N., Salmon, D. P., & Delis, D. C. (1994). Preclinical cognitive markers of dementia of the Alzheimer type. Neuropsychology, 8, 374–384.CrossRef

Bondi, M. W., Salmon, D. P., Galasko, D., Thomas, R. G., & Thal, L. J. (1999). Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychology and Aging, 14, 295–303.PubMedCrossRef

Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., & Small, G. W. (2000). Patterns of brain activation in people at risk for Alzheimer's disease. New England Journal of Medicine, 343, 450–456.PubMedCrossRef

Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica, 82, 239–259.PubMedCrossRef

Brewer, J. B., & Moghekar, A. (2002). Imaging the medial temporal lobe: Exploring new dimensions. Trends in Cognitive Science, 6, 217–223.CrossRef

Brown, G. G., Perthen, J., Liu, T. T., & Buxton, R. (2007). A primer on functional magnetic resonance imaging. Neuropsychology Review.

Buckner, R. L., Snyder, A. Z., Sanders, A. L., Raichle, M. E., & Morris, J. C. (2000). Functional brain imaging of young, nondemented, and demented older adults. Journal of Cognitive Neuroscience, 12(Suppl 2), 24–34.PubMedCrossRef

Burggren, A. C., Small, G. W., Sabb, F. W., & Bookheimer, S. Y. (2002). Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. American Journal of Geriatric Psychiatry, 10, 44–51.PubMedCrossRef

Buxton, R. B., Uludag, K., Dubowitz, D. J., & Liu, T. T. (2004). Modeling the hemodynamic response to brain activation. Neuroimage, 23(Suppl 1), S220–33.PubMedCrossRef

Caselli, R. J., Reiman, E. M., Osborne, D., Hentz, J. G., Baxter, L. C., Hernandez, J. L., & Alexanter, G. G. (2004). Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology, 62, 1990–1995.PubMed

Celone, K. A., Calhoun, V. D., Dickerson, B. C., Atri, A., Chua, E. F., Miller, S. L., DePeau, K., Rentz, D. M., Selkoe, D. J., Blacker, D., Albert, M. S., & Sperling, R. A. (2006). Journal of Neuroscience, 26, 10222–10231.PubMedCrossRef

Claus, J. J., Breteler, M. M., Hasan, D., Krenning, E. P., Bots, M. L., Grobbee, D. E., Van Swieten, J. C., Van Harskamp, F., & Hofman, A. (1998). Regional cerebral blood flow and cerebrovascular risk factors in the elderly population. Neurobiology of Aging, 19, 57–64.PubMedCrossRef

Collie, A., & Maruff, P. (2000). The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neuroscience and Biobehavioral Reviews, 24, 365–374.PubMedCrossRef

Corkin, S., Kennedy, A. M., Bucci, J., et al. (1997). Relation between recognition performance and fMRI data in Alzheimer's disease and older normal subjects. Society for Neuroscience, 23, 193–195.

Davis, T. L., Kwong, K. K., Weisskoff, R. M., & Rosen, B. R. (1998). Calibrated functional MRI: Mapping the dynamics of oxidative metabolism. Proceedings of the National Academy of Sciences, USA, 95, 1834–1839.CrossRef

Delano-Wood, L., Bozoki, A., & Abeles, N. (2006). Evidence for heterogeneity in mild cognitive impairment: Differences in neuropsychological profile and associated white matter lesion pathology. International Neuropsychological Society (published abstract).

Delano-Wood, L., Jak, A. J., Schweinsburg, B. C., Wierenga, C. E., Horne, N. R., Salmon, D. P., Thal, L. J., Frank, L. R., & Bondi, M. W. (2007). Posterior white matter changes in MCI: Associations with cognition and stroke risk. Journal of the International Neuropsychological Society (abstract).

Desgranges, B., Baron, J. D., de la Sayette, V., Petit-Taboue, M. C., Benali, K., Landeau, B., Lechevalier, B., & Eustache, F. (1998). The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain, 121, 611–631.PubMedCrossRef

D’Esposito, M., Deouell, L. Y., & Gazzaley, A. (2003). Alterations in the BOLD-fMRI signal with ageing and disease: A challenge for neuroimaging. Nature Reviews Neuroscience, 4, 863–72.PubMedCrossRef

Devanand, D. P., Pelton, G. H., Zamora, D., Liu, X., Tabert, M. H., Goodkind, M., Scarmeas, N., Braun, I., Stern, Y., & Mayeux, R. (2005). Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Archives of Neurology, 62, 975–980.PubMedCrossRef

Devi, G., Ottman, R., Tang, M. X., Marder, K., Stern, Y., & Mayeux, R. (2000). Familial aggregation of Alzheimer disease among whites, African Americans, and Caribbean Hispanics in northern Manhattan. Archives of Neurology, 57, 72–77.PubMedCrossRef

Dickerson, B. C., Salat, D. H., Bates, J. F., Atiya, M., Killiany, R. J., Greve, D. N., Dale, A. M., Stern, C. E., Blacker, D., Albert, M. S., & Sperling, R. A. (2004). Medial temporal lobe function and structure in mild cognitive impairment. Annals of Neurology, 56, 27–35.PubMedCrossRef

Dickerson, B. C., Salat, D. H., Greve, D. N., Chua, E. F., Rand-Giovannetti, E., Rentz, D. M., Bertram, L., Mullin, K., Tanzi, R. E., Blacker, D., Albert, M. S., & Sperling, R. A. (2005). Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology, 65, 404–411.PubMedCrossRef

Dickerson, B. C., & Sperling, R. A. (2005). Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease. NeuroRx, 2, 348–360.PubMedCrossRef

Edison, P., Archer, H. A., Hinz, R., Hammers, A., Pavese, N., Tai, Y. F., Hotton, G., Cutler, D., Fox, N., Kennedy, A., Rossor, M., & Brooks, D. J. (2007). Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study. Neurology, 68, 501–508.PubMedCrossRef

Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., Lu, B., & Weinberger, D. R. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112, 257–269.PubMedCrossRef

Festa, E. K., Insler, R. Z., Salmon, D. P., Paxton, J., Hamilton, J. M., & Heindel, W. C. (2005). Neocortical disconnectivity disrupts sensory integration in Alzheimer's disease. Neuropsychology, 19, 728–738.PubMedCrossRef

Filbey, F. M., Slack, K. J., Sunderland, T. P., & Cohen, R. M. (2006). Functional magnetic resonance imaging and magnetoencephalography differences associated with APOE epsilon 4 in young healthy adults. Neuroreport, 17, 1585–1590.PubMedCrossRef

Fleisher, A. S., Houston, W. S., Eyler, L. T., Frye, S., Jenkins, C., Thal, L. J., & Bondi, M. W. (2005). Identification of Alzheimer disease risk by functional magnetic resonance imaging. Archives of Neurology, 62, 1881–1888.PubMedCrossRef

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1976). ‘Mini-mental State.’ A practical method for grading the cognitive status of patients for the clinician. Journal of Psychiatry Research, 12, 189–198.CrossRef

Fratiglioni, L. (1993). Epidemiology of Alzheimer's disease. Issues of etiology and validity. Acta Neurologica Scandinavia Supplement, 145, 1–70.

Frisoni, G. B. (2007). Dementia: Important advances in research in 2006. Lancet Neurology, 6, 4–5.PubMedCrossRef

Frisoni, G. B., Scheltens, P., Galluzzi, S., Nobili, F. M., Fox, N. C., Robert, P. H., Soininen, H., Wahlund, L-O, Waldemar, G., & Salmon, E. (2006). Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: Consensus paper of the EADC. Journal of Neurology, Neurosurgery, and Psychiatry, 74, 1371–1381.CrossRef

Golay, X., Hendrikse, J., & Lim, T. C. (2004). Perfusion Imaging Using Arterial Spin Labeling. Topics in Magnetic Resonance Imaging, 15, 10–27.PubMedCrossRef

Golby, A., Silverberg, F., Race, E., Gabrieli, S., O’Shea, J., Knierim, K., Stebbins, G., & Gabrieli, J. (2005). Memory encoding in Alzheimer's disease: An fMRI study of explicit and implicit memory. Brain, 128, 773–787.PubMedCrossRef

Gopinath, K., Wierenga, C. E., Conway, T., Crosson, B., & Briggs, R. (2006). Differential BOLD hemodynamics in young and elderly: Emphasis on post-stimulus undershoot. Proceedings of the International Society for Magnetic Resonance in Medicine, 14.

Gould, R. L., Brown, R. G., Owen, A. M., Bullmore, E. T., Williams, S. C. R., & Howard, R. J. (2005). Functional neuroanatomy of successful paired associate learning in Alzheimer's disease. American Journal of Psychiatry, 162, 2049–2060.PubMedCrossRef

Greicius, M. D., Krasnow, B., Reiss, A. L., & Menon, V. (2003). Functional connectivity in the resting brain: A network analysis of the default mode hypothesis. Proceedings of the National Academy of Science, USA, 100, 253–258.CrossRef

Greicius, M. D., Srivastava, G., Reiss, A. L., & Menon, V. (2004). Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI. Proceedings of the National Academy of Sciences, USA, 101, 4637–4642.CrossRef

Grober, E., & Kawas, C. (1997). Learning and retention in preclinical and early Alzheimer's disease. Psychology and Aging, 12, 183–188.PubMedCrossRef

Gron, G., & Riepe, M. W. (2004). Neural basis for the cognitive continuum in episodic memory from health to Alzheimer disease. American Journal of Geriatric Psychiatry, 12, 648–652.PubMedCrossRef

Grossman, M., Koenig, P., Glosser, G., DeVita, C., Moore, P., Rhee, J., Detre, J., Alsop, D., & Gee, J. (2003). Neural basis for semantic memory difficulty in Alzheimer's disease: An fMRI study. Brain, 126, 292–311.PubMedCrossRef

Guye, M., Parker, G. J., Symms, M., Boulby, P., Wheeler-Kingshott, C. A., Salek-Haddadi, A., Barker, G. J., & Duncan, J. S. (2003). Combined functional MRI and tractography to demonstrate the connectivity of the human primary motor cortex in vivo. NeuroImage, 19, 1349–13460.PubMedCrossRef

Hamalainen, A., Pihlajamaki, M., Tanila, H., Hanninen, T., Niskanen, E., Tervo, S., Karjalainen, P. A., Vanninen, R. L., & Soininen, H. (2006). Increased fMRI responses during encoding in mild cognitive impairment. Neurobiology of Aging [Epub ahead of print].

Han, S. D., Drake, A. I., Cessante, L. M., Jak, A. J., Houston, W. S., Delis, D. C., Filoteo, J. V., & Bondi, M. W. (2007). APOE and TBI in a U.S. military population: Evidence of a neuropsychological compensatory mechanism? Journal of Neurology, Neurosurgery & Psychiatry [Epub ahead of print].

Han, S. D., Houston, W. S., Jak, A. J., Eyler, L. T., Nagel, B. J., Fleisher, A. S., Brown, G. G., Corey-Bloom, J., Salmon, D. P., Thal, L. J., & Bondi, M. W. (2006). Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemisphere compensatory response. Neurobiology of Aging [Epub ahead of print].

Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., & Weinberger, D. R. (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. Journal of Neuroscience, 23, 6690–6694.PubMed

Hoge, R. D., Atkinson, J., Gill, B., Crelier, G. R., Marrett, S., & Pike, G. B. (1999) Linear coupling between cerebral blood flow and oxygen consumption in activated human cortex. Proceedings of the National Academy of Sciences, USA, 96(16), 9403–9408.CrossRef

Houston, W. S., Delis, D. C., Lansing, A., Cobell, C., Jacobson, M., Salmon, D. P., & Bondi, M. W. (2005). Executive function asymmetry in older adults genetically at risk for Alzheimer's disease: Verbal versus design fluency. Journal of the International Neuropsychological Society, 11, 863–870.PubMedCrossRef

Huang, W., Qui, C., von Strauss, E., Winblad, B., Fratiglioni, L. (2004). APOE genotype, family history of dementia, and Alzheimer disease risk: A 6-year follow-up study. Archives of Neurology, 61, 1930–1934.PubMedCrossRef

Hyder, F. (2004). Neuroimaging with calibrated fMRI. Stroke, 35(11 Suppl 1), 2635–2641.PubMedCrossRef

Jacobs, D. M., Sano, M., Dooneief, G., Marder, K., Bell, K. L., & Stern, Y. (1995). Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology, 45, 957–962.PubMed

Jacobson, M. W., Delis, D. C., Lansing, A., Houston, W. S., Olsen, R., Wetter, S., Bondi, M. W., & Salmon, D. P. (2005a). Asymmetries in global and local processing in elderly with the APOE ε4 allele. Neuropsychology, 19, 822–829.PubMedCrossRef

Jacobson, M., Delis, D. C., Bondi, M. W., & Salmon, D. P. (2005b). Asymmetry in auditory and spatial attention span in normal elderly genetically at risk for Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology, 27, 240–253.PubMedCrossRef

Jacobson, M., Delis, D. C., Bondi, M. W., & Salmon, D. P. (2002). Do neuropsychological tests detect preclinical Alzheimer's disease: Individual-test versus cognitive-discrepancy score analysis. Neuropsychology, 16, 132–139.PubMedCrossRef

Johnson, S. C., Baxter, L. C., Susskind-Wilder, L., Connor, D. J., Sabbagh, M. N., & Caselli, R. J. (2004). Hippocampal adaptation to face repetition in healthy elderly and mild cognitive impairment. Neuropsychologia, 42, 980–989.PubMedCrossRef

Johnson, S. C., Saykin, A. J., Baxter, L. C., Flashman, L. A., Santulli, R. B., McAllister, T. W., & Mamourian, A. C. (2000). The relationship between fMRI activation and cerebral atrophy: Comparison of normal aging and Alzheimer disease. Neuroimage, 11, 179–187.PubMedCrossRef

Johnson, S. C., Schmitz, T. W., Trivedi, M. A., Ries, M. L., Torgerson, B., Carlsson, C., Asthana, S., Hermann, B., & Sager, M. A. (2006). The influence of Alzheimer disease family history and APOE e4 on mesial temporal lobe activation. Journal of Neuroscience, 26, 6069–6076.PubMedCrossRef

Jorm, A. F., Mather, K. A., Butterworth, P., Anstey, K. J., Christensen, H., & Easteal, S. (2007). APOE genotype and cognitive functioning in a large age-stratified population sample. Neuropsychology, 21, 1–8.PubMedCrossRef

Kantarci, K., Petersen, R. C., Boeve, B. F., Knopman, D. S., Weigand, S. D., O’Brien, P. C., Shiung, M. M., Smith, G. E., Ivnik, R. J., Tangalos, E. G., & Jack, C. R. (2005). DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology, 64, 902–904.PubMed

Kato, T., Knopman, D., & Liu, H. Y. (2001). Dissociation of regional activation in mild AD during visual encoding —a functional MRI study. Neurology, 57, 812–816.PubMed

Kawamura, J., Terayma, Y., Takashima, S., Obara, K., Pavol, M. A., Meyer, J. S., Mortel, K. F., & Weathers, S. (1993). Leuko-araiosis and cerebral perfusion in normal aging. Experimental Aging Research, 19, 225–240.PubMed

Kawas, C., & Katzman, R. (1999). The epidemiology of dementia and Alzheimer disease. In R. D. Terry, R. Katzman, K. L. Bick, & S. S. Sisodia (Eds.), Alzheimer disease (2nd edn.). New York: Raven Press.

Knopman, D. S., DeKosky, S. T., Cummings, J. L., Chui, H., Corey-Bloom, J., Relkin, N., Small, G. W., Miller, B., & Stevens, J. C. (2001). Practice parameter: Diagnosis of dementia (an evidence-based review). Neurology, 56, 1143–1153.PubMed

Lange, K. L., Bondi, M. W., Galasko, D. G., Delis, D. C., Salmon, D. P., & Thal, L. J. (2002). Decline in verbal memory during preclinical Alzheimer's disease: Examination of the effect of Apolipoprotein E genotype. Journal of the International Neuropsychological Society, 8, 943–955.PubMedCrossRef

La Rue, A., Matsuyama, S. S., McPherson, S., Sherman, J., & Jarvik, L. F. (1992). Cognitive performance in relatives of patients with probable Alzheimer's disease: An age at onset effect? Journal of Clinical and Experimental Neuropsychology, 14, 533–538.PubMed

Levy, J. A., Bergeson, J., Putnam, K., Rosen, V., Cohen, R., Lalonde, F., Mirza, N., Linker, G., & Sunderland, T. (2004). Context-specific memory and apolipoprotein E (ApoE) e4: Cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease. Journal of the International Neuropsychological Society, 10, 362–370.PubMedCrossRef

Li, S. C., & Lindenberger U. (1999). Cross-level unification: A computational exploration of the link between deterioration of neurotransmitter systems dedifferentiation of cognitive abilities in old age (pp. 103–146). In L. G. Nilsson & H. J. Markowitsch (Eds.), Cognitive neuroscience of memory. Seattle, WA: Hogrefe & Huber.

Lind, J., Ingvar, M., Persson, J., Sleegers, K., Van Broeckhoven, C., Adolfsson, R., Nilsson, L-G., & Nyberg, L. (2006a). Parietal cortex activation predicts memory decline in apolipoprotein E e4 carriers. NeuroReport, 17, 1683–1686.PubMedCrossRef

Lind, J., Persson, J., Ingvar, M., Larsson, A., Cruts, M., Van Broeckhoven, C., Adolfsson, R., Backman, L., Nilsson, L-G., Petersson, K. M., & Nyberg, L. (2006b). Reduced functional brain activity response in cognitively intact apolipoprotein E e4 carriers. Brain, 129, 1240–1248.PubMedCrossRef

Lustig, C., Snyder, A. Z., Ghakta, M., O’Brien, K. C., McAvoy, M., Raichle, M. E., Morris, J. C., & Buckner, R. L. (2003). Functional deactivations: Change with age and dementia of the Alzheimer type. Proceedings of the National Academy of Sciences, USA, 100, 14505–14509.CrossRef

Machulda, M. M., Ward, H. A., Borowski, B., Gunter, J. L., Cha, R. H., O’Brien, P. C., Petersen, R. C., Boeve, B. F., Knopman, D., Tang-Wai, D. F., Ivnik, R. J., Smith, G. E., Tangalos, E. G., & Jack, C. R. (2003). Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology, 61, 500–506.PubMed

Madden, D. J., Spaniol, J., Whiting, W. L., Bucor, B., Provenzale, J. M., Cabeza, R., White, L. E., & Huttel., S. A. (2006). Adult age differences in the functional neuroanatomy of visual attention: A combined fMRI and DTI study. Neurobiology of Aging, 28, 457–476.

Markus, H., & Cullinane, M. (2001). Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain, 124, 457–467.PubMedCrossRef

Masdeu, J. C., Zubieta, J. L., & Arbizu, J. (2005). Neuroimaging as a marker of the onset and progression of Alzheimer's disease. Journal of the Neurological Sciences, 236, 55–64.PubMedCrossRef

Matsuda, H. (2001). Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Annals of Nuclear Medicine, 15, 85–92.PubMedCrossRef

Mayeux, R., & Sano, M. (1999). Treatment of Alzheimer's disease. New England Journal of Medicine, 341, 1670–1679.PubMedCrossRef

Medina, D., de T.-M., Urresta, F., Gabrieli, J. D. E., Moseley, M., Fleischman, D., Bennett, D. A., Leurgans, S., Turner, D. A., & Stebbins, G. T. (2006). White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiology of Aging, 27, 663–672.PubMedCrossRef

Mondadori, C. R. A., Buchmann, A., Mustovic, H., Schmidt, C. F., Boesiger, P., Nitsch, R. M., Hock, C., Streffer, J., & Henke, K. (2006a). Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years. Brain, 129, 2908–2922.PubMedCrossRef

Mondadori, C. R. A., de Quervain, D.J-F., Buchmann, A., Mustovic, H., Wollmer, M. A., Schmidt, C. F., Boesiger, P., Hock, C., Nitsch, R. M., Papassotiropoulos, A., & Henke, K. (2006b). Better memory and neural efficiency in young apolipoprotein E e4 carriers. Cerebral Cortex [Epub ahead of print].

Mosconi, L., Brys, M., Glodzik-Sobanska, L., De Santi, S., Rusinek, H., & de Leon, M. J. (in press). Early detection of Alzheimer's disease using neuroimaging. Experimental Gerontology.

Muller, M. J., Greverus, D., Weibrich, C., Dellani, P. R., Scheurich, A., Stoeter, P., & Fellgiebel, A. (2007). Diagnostic utility of hippocampal size and mean diffusivity in amnestic MCI. Neurobiology of Aging, 28, 398–403.

Pariente, J., Cole, S., Henson, R., Clare, L., Kennedy, A., Rossor, M., Cipoloti, L., Puel, M., Demonet, J. F., Chollet, F., & Frackowiak, R. S. J. (2005). Alzheimer's patients engage an alternative network during a memory task. Annals of Neurology, 58, 870–879.PubMedCrossRef

Peck, K. K., Wierenga, C. E., Bacon Moore, A., Maher, L., Gopinath, K., Gaiefsky, M., Briggs, R. W., & Crosson, B. (2004). Comparison of baseline conditions to investigate syntactic production using functional magnetic resonance imaging. NeuroImage, 23, 104–110.PubMedCrossRef

Persson, J., Lind, J., Larsson, A., Ingvar, M., Cruts, M., Van Broeckhoven, C., Adolfsson, R., Nilsson, L. G., & Nyberg, L. (2006). Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Neurology, 66, 1029–1033.PubMedCrossRef

Petersen, R. C. (2006). Mild cognitive impairment: Where are we? Alzheimer Disease Association Dis, 19, 166–169.CrossRef

Petersen, R. C., & Morris, J. C. (2005). Mild cognitive impairment as a clinical entity and treatment target. Archives of Neurology, 62, 1160–1166.PubMedCrossRef

Petersen, R. C., Smith, G., Ivnik, R. J., Tangalos, E. G., Schaid, D. J., Thibodeau, S. N., Kokmen, E., Waring, S. C., & Kurland, L. T. (1995). APOE status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. Journal of the American Medical Association, 273, 1274–1278.PubMedCrossRef

Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology, 56, 303–308.PubMedCrossRef

Petrella, J. R., Coleman, R. E., & Doraiswamy, P. M. (2003). Neuroimaging and early diagnosis of Alzheimer disease: A look to the future. Radiology, 226, 315–336.PubMedCrossRef

Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001). A default mode of brain function. Proceedings of the National Academy of Sciences, USA, 98, 676–682.

Rajah, M. N., & D’Esposito, M. (2005). Region-specific changes in prefrontal function with age: a review of PET and fMRI studies on working and episodic memory. Brain, 128(Pt 9), 1964–1983.PubMedCrossRef

Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996). Preclinical evidence of Alzheimer's disease in persons homozygous for the e4 allele for apolipoprotein E. The New England Journal of Medicine, 334, 752–758.PubMedCrossRef

Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004). Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proceedings of the National Academy of Sciences, USA, 101, 284–289.

Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2005). Correlations between apolipoprotein E e4 gene dose and brain-imaging measurements of regional hypometabolism. Proceedings of the National Academy of Sciences, USA, 102, 8299–8302.CrossRef

Reiman, E. M., Uecker, A., Caselli, R. J., Lewis, S., Bandy, D., de Leon, M. J., De Santi, S., Convit, A., Osborne, D., Weaver, A., & Thibodeau, S. N. (1998). Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Annals of Neurology, 44, 288–291.PubMedCrossRef

Restom, K., Perthen, J. E., Ances, B. M., & Liu, T. T. (2007). Calibrated BOLD in the medial temporal lobe during a memory encoding task. Proceedings of the International Society for Magnetic Resonance in Medicine (abstract).

Roberts, W., Dember, W. N., & Brodwick, M. (1962). Alternation and exploration in rats with hippocampal lesions. Journal of Computational and Physiological Psychology, 55, 695.CrossRef

Rombouts, S. A. R. B., Barkhof, F., Goekoop, R., Stam, C. J., & Scheltens, P. (2005a). Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: An fMRI study. Human Brain Mapping, 26, 231–239.PubMedCrossRef

Rombouts S.A.R.B., Barkhof, F., Veltman, D. J., Machielsen, W. C. M., Witter, M. P., Bierlaagh, M. A., Lazeron, R. H. C., Valk, J., & Scheltens, P. (2000). Functional MR imaging in Alzheimer's disease during memory encoding. American Journal of Neuroradiology, 21, 1869–1875.PubMed

Rombouts, S. A. R. B., Goekoop, R., Stam, C. J., Barkhof, F., & Scheltens, P. (2005b). Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease. Neuroimage, 26, 1078–1085.PubMedCrossRef

Rose, S. E., McMahon, K. L., Janke, A. L., O’Dowd, B., de Zubicaray, G., Strudwick, M. W., & Chalk, J. B. (2006). MRI diffusion indices and neuropsychological performance in amnestic mild cogntive impairment. Journal of Neurology Neurosurgery and Psychiatry, 77, 1122–1128.

Sager, M. A., Hermann, B., & La Rue, A. (2005). Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention. Journal of Geriatric Psychiatry and Neurology, 18, 245–249.PubMedCrossRef

Salmon, D. P., & Bondi, M. W. (2008). Neuropsychology of aging and dementia. Annual Review of Psychology.

Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Perick-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., Hulette, C., Crain, B., Goldgaber, D., & Roses, A. D. (1993). Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43, 1467–1472.PubMed

Saykin, A. J., Flashman, L. A., Frutiger, S. A., Johnson, S. C., Mamourian, A. C., Moritz, C. H., O’Jile, J. R., Riordan, H. J., Santulli, R. B., Smith, C. A., & Weaver, J. B. (1999). Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: Patterns of functional MRI activation. Journal of the International Neuropsychological Society, 5, 377–392.PubMedCrossRef

Slooter, A. J. C., Breteler, M. M. B., Ott, A., Van Broeckhoven, C., & Van Duijn, C. M. (1996). APOE genotyping in differential diagnosis of Alzheimer's disease. The Lancet, 348, 334.CrossRef

Small, G. W., Ercoli, L. M., Silverman, D. H., Huang, S. C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., Mazziotta, J. C., Sexena, S., Wu, H. M., Mega, M. S., Cummings, J. L., Saunders, A. M., Pericak-Vance, M. A., Roses, A. D., Barrio, J. R., & Phelps, M. E. (2000a). Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proceedings of the National Academy of Science, USA, 97, 6037–6042.

Small, S. A., Nava, A. S., Perera, G. M., Delapaz, R., & Stern, Y. (2000b). Evaluating the function of hippocampal subregions with high-resolution MRI in Alzheimer's disease and aging. Microscopy Research and Technique, 51, 101–108.PubMedCrossRef

Small, G. W., Kepe, V., Ercoli, L. M., Siddarth, P., Bookheimer, S. Y., Miller, K. J., Lavretsky, H., Burggren, A. C., Cole, G. M., Vinters, H. V., Thompson, P. M., Huang, S. C., Satyamurthy, N., Phelps, M. E., & Barrio, J. R. (2006). PET of brain amyloid and tau in mild cognitive impairment. New England Journal of Medicine, 21, 2652–2663.CrossRef

Small, S. A., Perera, G. M., DeLaPaz, R., Mayeux, R., & Stern, Y. (1999). Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Annals of Neurology, 45, 466–472.PubMedCrossRef

Smith, C. D., Andersen, A. H., Kryscio, R. J., Schmitt, F. A., Kindy, M. S., Blonder, L. X., & Avison, M. J. (1999). Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology, 53, 1391–1396.PubMed

Smith, C. D., Andersen, A. H., Kryscio, R. J., Schmitt, F. A., Kindy, M. S., Blonder, L. X., & Avison, M. J. (2002). Women at risk for AD show increased parietal activation during a fluency task. Neurology, 58, 1197–1202.PubMed

Smith, C. D., Kryscio, R. J., Schmitt, F. A., Lovell, M. A., Blonder, L. X., Rayens, W. S., & Andersen, A. H. (2005). Longitudinal functional alterations in asymptomatic women at risk for Alzheimer's disease. Journal of Neuroimaging, 15, 271–277.PubMedCrossRef

Smith, S. M., Jenkinson, M., Johansen-Berg, H., Rueckert, D., Nichols, T. E., Mackay, C. E., Watkins, K. E., Ciccarelli, O., Cader, M. Z. Matthews, P. M., & Behrens, T. E. (2006). Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage, 31, 1487–1505.PubMedCrossRef

Sperling, R. A., Bates, J. F., Chua, E. F., Cocchiarella, A. J., Rentz, D. M., Rosen, B. R., Schacter, D. L., & Albert, M. S. (2003). fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 74, 44–50.PubMedCrossRef

Squire, L. R. (1992). Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans. Psychological Review, 99, 195–231.PubMedCrossRef

Stefanovic, B., Warnking, J. M., Rylander, K. M., & Pike, G. B. (2005). The effect of global cerebral vasodilation on focal activation hemodynamics. Neuroimage.

Stoub, T. R., de T.-M., Stebbins, G. T., Leurgans, S., Bennett, D. A., & Shah, R. C. (2006). Hippocampal disconnection contributes to memory dysfunction individuals at risk for Alzheimer's disease. Proceedings of the National Academy of Sciences, USA, 103, 10041–10045.

Sunderland, T., Hampal, H., Takeda, M., Putnam, K. T., & Cohen, R. M. (2006). Biomarkers in the diagnosis of Alzheimer's disease: Are we ready? Journal of Geriatric Psychiatry and Neurology, 19, 172–179.PubMedCrossRef

Takada, H., Nagata, K., Hirata, Y., Satoh, Y., Watahiki, Y., Sugawara, J., Yokoyama, E., Kondoh, Y., Shishido, F., Inugami, A., et al. (1992). Age-related decline of cerebral oxygen metabolism in normal population detected with positron emission tomography. Neurological Research, 14(2 Suppl), 128–131.PubMed

Takahashi, E., Ohki, K., & Kim, D. (2007). Diffusion tensor studies dissociated two fronto-temporal pathways in the human memory system. NeuroImage, 34, 827–838.PubMedCrossRef

Tariot, P. N., & Federoff, H. J. (2003). Current treatment for Alzheimer disease and future prospects. Alzheimer Disease and Associated Disorders, 17(4 Suppl), 105–113.

Tekes, A., Mohamed, M. A., Browner, N. M., Calhoun, V. D., & Yousem, D. M. (2005). Effect of age on visuomotor functional MR imaging. Academy of Radiology, 12, 739–745.CrossRef

Terry, R. D., Masliah, E., & Hansen, L. A. (1999). The neuropathology of Alzheimer disease and the structural basis of its cognitive alterations. In R. D. Terry, R. Katzman, K. L. Bick, & S. S. Sisodia (Eds.), Alzheimer disease (2nd edn.). Philadelphia: Lippincott Williams & Wilkins.

Tiraboschi, P., Hansen, L. A., Masliah, E., Alford, M., Thal, L. J., & Corey-Bloom, J. (2004). Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology, 62, 1977–1983.PubMed

Tohgi, H., Takahashi, S., Kato, E., Homma, A., Niina, R., Sasaki, K., Yonezawa, H., & Sasaki, M. (1997). Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele. Neuroscience Letters, 236, 21–24.PubMedCrossRef

Toosy, A. T., Ciccarelli, O., Parker, G. J., Wheeler-Kingshott, C. A., Miller, D. H., & Thompson, A. J. (2004). Characterizing function-structure relationships in the human visual system with functional MRI and diffusion tensor imaging. NeuroImage, 21, 1452–1463.PubMedCrossRef

Trivedi, M. A., Schmitz, T. W., Ries, M., Torgerson, B. M., Sager, M. A., Hermann, B. P., Asthana, S., & Johnson, S. C. (2006). Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: A cross-sectional study. BioMed Central, 4, 1–14.

Twamley, E. W., Ropacki, S., & Bondi, M. W. (2006). Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease. Journal of the International Neuropsychological Society, 12, 707–735.PubMedCrossRef

Uspenskaia, O., Liebetrau, M., Herms, J., Danek, A., & Hamann, G. F. (2004). Aging is associated with increased collagen type IV accumulation in the basal lamina of human cerebral microvessels. BioMed Central Neuroscience, 5, 37.PubMed

Valdes-Sosa, P. A., Kotter, R., & Friston, K. J. (2005). Introduction: Multimodal neuroimaging of brain connectivity. Phil Trans R Soc B, 360, 865–867.PubMedCrossRef

van Duijn, C. M., Clayton, D., Chandra, V., Fratiglioni, L., Graves, A. B., Heyman, A., Jorm, A. F., Kokmen, E., Kondo, K., & Mortimer, J. A. (1991). Familial aggregation of Alzheimer's disease and related disorders: A collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. International Journal of Epidemiology, 20(Suppl 2), 13–20.

Vinogradova, O. S. (2001). Hippocampus as comparator: Role of the two input and two output systems of the hippocampus in selection and registration of information. Hippocampus, 11, 578–598.PubMedCrossRef

Wang, P. J., Saykin, A. J., Flashman, L. A., Wishart, H. A., Rabin, L. A., Santulli, R. B., McHugh, T. L., MacDonald, J. W., & Mamouriuan, A. C. (2006). Regionally specific atrophy of the corpus callosum in AD, MCIl and cognitive complaints. Neurobiology of Aging, 27, 1613–1617.PubMedCrossRef

Wang, L., Zang, Z., He, Y., Liang, M., Zhang, X., Tian, L., Wu, T., Jiang, T., & Li, K. (2006). Changes in hippocampal connectivity in the early stages of Alzheimer's disease: Evidence from resting state fMRI. Neuroimage, 31, 496–504.PubMedCrossRef

Wetter, S., Delis, D. C., Houston, W. S., Jacobson, M., W., Lansing, A., Cobell, K., Salmon, D. P., & Bondi, M. W. (2006). Heterogeneity in verbal memory: A marker of preclinical Alzheimer's disease? Aging, Neuropsychology, and Cognition, 13, 503–515.CrossRef

Wetter, S., Delis, D. C., Houston, W. S., Jacobson, M. W., Lansing, A., Cobell, K., Salmon, D. P. & Bondi, M. W. (2005). Deficits in inhibition and flexibility are associated with the APOE ε4 allele in nondemented older adults. Journal of Clinical and Experimental Neuropsychology, 27, 943–952.PubMedCrossRef

Wierenga, C. E., Benjamin, M., Gopinath, K., Perlstein, W. M., Leonard, C. M., Rothi, L. J., Conway, T., Cato, M. A., Briggs, R., & Crosson, B. (2006). Age-related changes in word retrieval: Role of bilateral frontal and subcortical networks. Neurobiology of Aging [Epub ahead of print].

Wishart, H. A., Saykin, A. J., Rabin, L. A., Santulli, R. B., Flashman, L. A., Guerin, S. J., Mamourian, A. C., Belloni, D. R., Rhodes, C. H., & McAllister, T. W. (2006). Increased brain activation during working memory in cognitively intact adults with the APOE e4 allele. American Journal of Psychiatry, 163, 1603–1610.PubMedCrossRef

Wolf, H., Jelic, V., Gertz, H-J., Nordberg, A., Julin, P., & Wahlund, L-O. (2003). A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurologica Scandinavica, 107(s179), 52–76.CrossRef

Woodard, J. L., Grafton, S. T., Votaw, J. R., Green, R. C., Dobraski, M. E., & Hoffman, J. M. (1998). Compensatory recruitment of neural resources during overt rehearsal of word lists in Alzheimer's disease. Neuropsychology, 12, 491–504.PubMedCrossRef

Yamaguchi, T., Kanno, I., Uemura, K., Shishido, F., Inugami, A., Ogawa, T., Murakami, M., & Suzuki, K. (1986). Reduction in regional cerebral metabolic rate of oxygen during human aging. Stroke, 17, 1220–1228.PubMed

Yamamoto, M., Meyer, J. S., Sakai, F., & Yamaguchi, F. (1980). Aging and cerebral vasodilator responses to hypercarbia: responses in normal aging and in persons with risk factors for stroke. Archives of Neurology, 37, 489–496.PubMed

Yip, A. G., McKee, A. C., Green, R. C., Wells, J., Young, H., Cupples, L. A., & Farrer, L. A. (2005). APOE, vascular pathology, and the AD brain. Neurology, 65, 259–265.PubMedCrossRef

Titel: Use of Functional Magnetic Resonance Imaging in the Early Identification of Alzheimer's Disease
verfasst von: Christina E. Wierenga
Mark W. Bondi
Publikationsdatum: 01.06.2007
Verlag: Springer US
Erschienen in: Neuropsychology Review / Ausgabe 2/2007
Print ISSN: 1040-7308
Elektronische ISSN: 1573-6660
DOI: https://doi.org/10.1007/s11065-007-9025-y

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Use of Functional Magnetic Resonance Imaging in the Early Identification of Alzheimer's Disease

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2007

Functional MRI of Language in Aphasia: A Review of the Literature and the Methodological Challenges

Functional Magnetic Resonance Imaging in Clinical Practice: Look Before You Leap

Meta-Analysis of Neuropsychological Symptoms of Adolescents and Adults with PKU

Clinical Use of Functional Magnetic Resonance Imaging: Reflections on the New CPT Codes

Pre-Surgical Language Mapping with Functional Magnetic Resonance Imaging

A Primer on Functional Magnetic Resonance Imaging

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

Update Neurologie